News
Paxlovid is an antiviral combination therapy that can reduce the risk of COVID-19 causing severe illness, hospitalization and ...
The data from this prospective cohort study confirm and expand previous retrospective case series that have found factors, including hematologic cancers, chemotherapy receipt, and lung cancer, as ...
COVID-19 is rising in prevalence in many states nationally following the July 4 holiday week, but the role of the main therapy to treat it—the antiviral drug Paxlovid—is less clear.
COVID-19 activity is yet again on the rise in Hawaii, according to the latest report from the Hawaii Department of Health.
Dr. Amir Kol realized the striking parallels between FIP and severe COVID-19 could offer hope for millions of long COVID ...
Despite offering significant protection against severe COVID-19, patients with cancer, a high-risk group, showed low uptake of booster vaccinations.
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
“Some people think that if they got the vaccine or feel healthy, they don’t need treatment,” said Karyne Jones, President and CEO of NCBA, Inc. and co-convener of CVEEP. “But that’s not always true.
Citing prolonged custody, delay in trial, and parity with a co-accused, the Bombay High Court granted bail to businessman ...
A new study from Northwestern University found that life expectancy in California has not returned to pre-pandemic levels, ...
Since the onset of the COVID-19 pandemic, the prevalence of obesity in Canada has increased at a greater rate.
11h
The Chosun Ilbo on MSNCOVID-19 on the rise again as patients hit 2-month high in S. KoreaAn office worker surnamed Lee recently experienced high fever, chills, and muscle pain. At first, Lee thought it was just a summer cold or air conditioning sickness and took cold medicine. But ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results